Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
TFX Stock Forecast 2026-2027
$134.61
Current Price
$5.96B
Market Cap
Buy 5
Hold 7
Sell 0
Wall St Analyst Ratings
Distance to TFX Price Targets
+18.9%
To High Target of $160.00
+8.5%
To Median Target of $146.00
+0.3%
To Low Target of $135.00
TFX Price Momentum
-0.8%
1 Week Change
+6.0%
1 Month Change
+21.2%
1 Year Change
+10.3%
Year-to-Date Change
-3.6%
From 52W High of $139.67
+34.4%
From 52W Low of $100.18
📊 TOP ANALYST CALLS
Did TFX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Teleflex is one of their latest high-conviction picks.
Latest TFX Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, TFX has a neutral consensus with a median price target of $146.00 (ranging from $135.00 to $160.00). The overall analyst rating is Buy (7.0/10). Currently trading at $134.61, the median forecast implies a 8.5% upside. This outlook is supported by 5 Buy, 7 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TFX Analyst Ratings
5
Buy
7
Hold
0
Sell
TFX Price Target Range
Low
$135.00
Average
$146.00
High
$160.00
Current: $134.61
Latest TFX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TFX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 15, 2026 | Mizuho | Anthony Petrone | Neutral | Maintains | $145.00 |
| Jul 9, 2026 | BMO Capital | Vik Chopra | Outperform | Initiates | $159.00 |
| Jun 8, 2026 | Piper Sandler | Overweight | Upgrade | $N/A | |
| May 11, 2026 | Truist Securities | Hold | Reiterates | $N/A | |
| May 8, 2026 | RBC Capital | Outperform | Upgrade | $N/A | |
| May 8, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Mar 27, 2026 | Raymond James | Outperform | Upgrade | $N/A | |
| Feb 27, 2026 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Feb 27, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Feb 26, 2026 | Needham | Buy | Maintains | $N/A | |
| Jan 29, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Jan 27, 2026 | Needham | Buy | Upgrade | $N/A | |
| Dec 18, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Dec 10, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Nov 10, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Nov 7, 2025 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Nov 7, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Aug 1, 2025 | Mizuho | Neutral | Maintains | $N/A | |
| Aug 1, 2025 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Aug 1, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A |
Teleflex Incorporated (TFX) Competitors
The following stocks are similar to Teleflex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Teleflex Incorporated (TFX) Financial Data
Teleflex Incorporated has a market capitalization of $5.96B with a P/E ratio of 1,931.7x. The company generates $2.13B in trailing twelve-month revenue with a -47.4% profit margin.
Revenue growth is +32.3% quarter-over-quarter, while maintaining an operating margin of +8.4% and return on equity of +0.0%.
Valuation Metrics
Market Cap
$5.96B
Enterprise Value
$8.24B
P/E Ratio
1,931.7x
PEG Ratio
-17.8x
Price/Sales
2.8x
Growth & Margins
Revenue Growth (YoY)
+32.3%
Gross Margin
+56.1%
Operating Margin
+8.4%
Net Margin
-47.4%
EPS Growth
-21.8%
Financial Health
Cash/Price Ratio
+5.6%
Current Ratio
2.6x
Debt/Equity
88.8x
ROE
+0.0%
ROA
+2.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Teleflex Incorporated (TFX) Business Model
About Teleflex Incorporated
What They Do
Develops and distributes single-use medical devices.
Business Model
Teleflex Incorporated generates revenue by designing, manufacturing, and selling innovative single-use medical devices across various healthcare segments including critical care, surgery, and emergency medicine. The company’s diverse product offerings cater to critical clinical areas such as cardiac care, anesthesia, and vascular access, ensuring a steady demand for its solutions in hospitals and healthcare settings.
Additional Information
Headquartered in Wayne, Pennsylvania, Teleflex operates in over 40 countries with a workforce of more than 14,000 employees. Its well-known brands, including Arrow and QuikClot, highlight its significant presence in the global healthcare market, providing high-quality products that enhance patient health and quality of life.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,500
CEO
Mr. Stuart A. Randle
Country
United States
IPO Year
1988
Website
www.teleflex.comTeleflex Incorporated (TFX) Latest News & Analysis
Latest News
Teleflex Publishes 2025 Global Impact Report
11 days ago
Quick Summary
Teleflex Incorporated (NYSE: TFX) has released its 2025 Global Impact Report, detailing achievements and future CSR plans, aligning with GRI, SASB, and TCFD standards.
Why It Matters
Teleflex's Global Impact Report signals commitment to CSR and sustainability, potentially enhancing its reputation and appeal to socially responsible investors, which may boost stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Investors should monitor TFX stock due to recent activity in the options market.
Why It Matters
Increased activity in TFX options may indicate significant price movement expectations, suggesting volatility or potential shifts in investor sentiment, impacting stock performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Teleflex Incorporated (NYSE: TFX) has begun enrollment for the BIOMAG™‑III Study, evaluating the Freesolve™ Resorbable Magnesium Scaffold, with the first U.S. implanter from MedStar Health.
Why It Matters
Teleflex's enrollment in a pivotal study for its innovative Freesolve™ RMS could lead to regulatory approval, enhancing product offerings and driving future revenue growth, impacting stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Teleflex Incorporated (NYSE: TFX) reported positive four-year follow-up data from the BIOMAG™-I Clinical Study, indicating a favorable long-term safety profile for its medical technology.
Why It Matters
Teleflex's positive four-year data on the BIOMAG™-I study suggests strong long-term safety for their medical technology, potentially boosting investor confidence and market performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Teleflex's portfolio reset is impacting results, but a lower valuation and proceeds from divestitures may improve its outlook in the next 6-12 months.
Why It Matters
Teleflex's portfolio reset may impact short-term performance, but a lower valuation and potential cash from divestitures could enhance future growth prospects, influencing investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032
1 month ago
Quick Summary
Teleflex Incorporated (NYSE: TFX) has launched a private offering of $500 million in senior notes due 2032, with terms to be determined at pricing. The notes will be guaranteed by its wholly-owned subsidiaries.
Why It Matters
Teleflex's $500 million senior notes offering indicates its strategy for capital raising, impacting liquidity and potential growth, which can influence stock performance and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About TFX Stock
What is Teleflex Incorporated's (TFX) stock forecast for 2027?
Based on our analysis of 6 Wall Street analysts, Teleflex Incorporated (TFX) has a median price target of $146.00. The highest price target is $160.00 and the lowest is $135.00.
Is TFX stock a good investment in 2027?
According to current analyst ratings, TFX has 5 Buy ratings, 7 Hold ratings, and 0 Sell ratings. The stock is currently trading at $134.61. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TFX stock?
Wall Street analysts predict TFX stock could reach $146.00 in the next 12 months. This represents a 8.5% increase from the current price of $134.61. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Teleflex Incorporated's business model?
Teleflex Incorporated generates revenue by designing, manufacturing, and selling innovative single-use medical devices across various healthcare segments including critical care, surgery, and emergency medicine. The company’s diverse product offerings cater to critical clinical areas such as cardiac care, anesthesia, and vascular access, ensuring a steady demand for its solutions in hospitals and healthcare settings.
What is the highest forecasted price for TFX Teleflex Incorporated?
The highest price target for TFX is $160.00 from at , which represents a 18.9% increase from the current price of $134.61.
What is the lowest forecasted price for TFX Teleflex Incorporated?
The lowest price target for TFX is $135.00 from at , which represents a 0.3% increase from the current price of $134.61.
What is the overall TFX consensus from analysts for Teleflex Incorporated?
The overall analyst consensus for TFX is neutral. Out of 6 Wall Street analysts, 5 rate it as Buy, 7 as Hold, and 0 as Sell, with a median price target of $146.00.
How accurate are TFX stock price projections?
Stock price projections, including those for Teleflex Incorporated, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 7:12 AM UTC